Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma.

Allen C, Duffy S, Teknos T, Islam M, Chen Z, Albert PS, Wolf G, Van Waes C.

Clin Cancer Res. 2007 Jun 1;13(11):3182-90.

2.

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.

Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, Vilela RJ, Ende K, McCullagh L, Rudy SF, Muir C, Herscher LL, Morris JC, Albert PS, Van Waes C.

Head Neck. 2005 Sep;27(9):771-84.

PMID:
15920746
3.

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.

Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG.

J Clin Oncol. 2000 May;18(10):2046-52.

PMID:
10811669
4.

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.

Polimeno M, Napolitano M, Costantini S, Portella L, Esposito A, Capone F, Guerriero E, Trotta A, Zanotta S, Pucci L, Longo N, Perdonà S, Pignata S, Castello G, Scala S.

BJU Int. 2013 Sep;112(5):686-96. doi: 10.1111/bju.12068. Epub 2013 Mar 15.

5.

Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.

Ren Y, Cao B, Law S, Xie Y, Lee PY, Cheung L, Chen Y, Huang X, Chan HM, Zhao P, Luk J, Vande Woude G, Wong J.

Clin Cancer Res. 2005 Sep 1;11(17):6190-7.

6.

Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.

Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, Haffty BG.

Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):780-5.

PMID:
11448349
7.

Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.

Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C.

Clin Cancer Res. 1999 Jun;5(6):1369-79.

8.

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.

Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG.

Cytokine. 2011 Dec;56(3):616-20. doi: 10.1016/j.cyto.2011.08.034. Epub 2011 Sep 21.

PMID:
21940178
9.

Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.

Seibold ND, Schild SE, Bruchhage KL, Gebhard MP, Noack F, Rades D.

Strahlenther Onkol. 2013 Aug;189(8):639-46. doi: 10.1007/s00066-013-0341-2. Epub 2013 Jun 9. Erratum in: Strahlenther Onkol. 2014 Mar;190(3):324. Bruchhage, K L [added].

PMID:
23748230
11.

Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.

Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.

Cancer Res. 2005 Aug 15;65(16):7071-80.

12.

Clinicopathologic significance of nuclear factor-κB and vascular endothelial growth factor expression in advanced gastric cancer patients.

Park KW, Kim SJ, Oh SY.

Oncol Res Treat. 2014;37(4):183-90. doi: 10.1159/000360777. Epub 2014 Mar 20.

PMID:
24732642
13.

Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.

St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT.

Arch Otolaryngol Head Neck Surg. 2004 Aug;130(8):929-35.

PMID:
15313862
14.

Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.

Seibold ND, Schild SE, Gebhard MP, Noack F, Schröder U, Rades D.

Strahlenther Onkol. 2013 Jul;189(7):559-65. doi: 10.1007/s00066-013-0320-7. Epub 2013 May 24. Erratum in: Strahlenther Onkol. 2014 Mar;190(3):325. Schröder, U [added].

PMID:
23700207
15.

Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.

Self EM, Bumpous J, Ziegler C, Wilson L, Potts K.

JAMA Otolaryngol Head Neck Surg. 2013 Apr;139(4):356-61. doi: 10.1001/jamaoto.2013.103.

PMID:
23599070
16.

Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.

Tsuzuki H, Sunaga H, Ito T, Narita N, Sugimoto C, Fujieda S.

Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1071-8.

PMID:
16365220
17.

Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma.

Miyahara K, Nouso K, Tomoda T, Kobayashi S, Hagihara H, Kuwaki K, Toshimori J, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K.

J Gastroenterol Hepatol. 2011 Nov;26(11):1604-11. doi: 10.1111/j.1440-1746.2011.06887.x.

PMID:
22011296
18.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
20.

The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.

Ljøkjel B, Haave H, Lybak S, Aarstad HH, Karlsdottir A, Vintermyr OK, Aarstad HJ.

Acta Otolaryngol. 2014 Sep;134(9):964-73. doi: 10.3109/00016489.2014.927590. Epub 2014 Jun 25.

PMID:
24963968

Supplemental Content

Support Center